Michael David M.d. Katz - 05 Feb 2026 Form 4 Insider Report for Hanover Bancorp, Inc. /MD (HNVR)

Role
Director
Signature
/s/ Michael David Katz M.D.
Issuer symbol
HNVR
Transactions as of
05 Feb 2026
Net transactions value
$0
Form type
4
Filing time
09 Feb 2026, 14:48:20 UTC
Previous filing
31 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Katz Michael David M.D. Director C/O HANOVER BANCORP, INC., 80 EAST JERICHO TURNPIKE, MINEOLA /s/ Michael David Katz M.D. 09 Feb 2026 0001919798

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HNVR Common Stock Award $0 +1,592 +1.1% $0.000000 152,202 05 Feb 2026 Direct F1
holding HNVR Common Stock 25 05 Feb 2026 By Custodian for Grandchild #1
holding HNVR Common Stock 40 05 Feb 2026 By Custodian for Grandchild #2
holding HNVR Common Stock 96,760 05 Feb 2026 By Trust - Beneficiary
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029.